Skip to main content

REVIEW article

Front. Cardiovasc. Med.
Sec. Heart Failure and Transplantation
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1388232

Device Therapies in Heart Failure with reduced Ejection Fraction: A New Era

Provisionally accepted
Rohit Mody Rohit Mody 1*Abha Bajaj Nee Sheth Abha Bajaj Nee Sheth 2Debabrata Dash Debabrata Dash 3Bhavya Mody Bhavya Mody 4Ankit Agrawal Ankit Agrawal 5Inderjeet Singh Monga Inderjeet Singh Monga 6Lakshay Rastogi Lakshay Rastogi 4Amit Munjal Amit Munjal 7
  • 1 Mody Harvard Cardiac Institute & Research Centre- Krishna Super Specialty Hospital, Bathinda, India
  • 2 Dr. Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, Chandigarh, India
  • 3 aster hospital, Mankhool, Dubai, Dubai, United Arab Emirates
  • 4 Kasturba Medical College, Manipal, India
  • 5 Cleveland Clinic, Cleveland, Ohio, United States
  • 6 command hospital chandimandir, Haryana, India
  • 7 Dr Asha Memorial Munjal Multispeciality Hospital, Fatehabad, India

The final, formatted version of the article will be published soon.

    Even with significant advancements in the treatment modalities for patients with Heart Failure (HF), the rates of morbidity and mortality associated with HF are still high. Various therapeutic interventions, including cardiac resynchronization therapy, implantable cardiovascular-defibrillators (ICDs), and Left Ventricular Assist Devices (LVADs), are used for HF management. Currently, more research and developments are required to identify different treatment modalities to reduce hospitalization rates and improve the Quality of Life (QOL) of patients with HF. In relation to this, various nonvalvular catheter-based therapies have been recently developed for managing chronic HF. These devices target the pathophysiological processes involved in HF development including neurohumoral activation, congestion, and left ventricular remodeling. The present review article aimed to discuss the major transcatheter devices used in managing chronic HF. The rationale and current clinical developmental stages of these interventions will also be addressed in this review.

    Keywords: congestive heart failure, Implantable catheters, device, minimally invasive surgery, cardiac resynchronization

    Received: 19 Feb 2024; Accepted: 02 Sep 2024.

    Copyright: © 2024 Mody, Nee Sheth, Dash, Mody, Agrawal, Monga, Rastogi and Munjal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Rohit Mody, Mody Harvard Cardiac Institute & Research Centre- Krishna Super Specialty Hospital, Bathinda, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.